Literature DB >> 19846469

Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.

M Kolpen1, C R Hansen, T Bjarnsholt, C Moser, L D Christensen, M van Gennip, O Ciofu, L Mandsberg, A Kharazmi, G Döring, M Givskov, N Høiby, P Ø Jensen.   

Abstract

BACKGROUND: Chronic lung infection with Pseudomonas aeruginosa is the most severe complication for patients with cystic fibrosis (CF). This infection is characterised by endobronchial mucoid biofilms surrounded by numerous polymorphonuclear leucocytes (PMNs). The mucoid phenotype offers protection against the PMNs, which are in general assumed to mount an active respiratory burst leading to lung tissue deterioration. An ongoing respiratory burst by the PMNs has, however, not been demonstrated previously in endobronchial secretions from chronically infected patients with CF.
OBJECTIVE: Based on the accumulating evidence for depletion of molecular oxygen (O(2)) in the mucus in infected CF bronchi, it was hypothesised that the O(2) depletion in the mucus in infected CF bronchi may be accelerated by the respiratory burst of the PMNs due to the reduction of O(2) to the superoxide anion (O(-)(2)) by the phagocyte NADPH oxidase (Phox).
METHODS: Methods were established to isolate the O(2) consumption by the respiratory burst from aerobic respiration in freshly expectorated sputum from chronically infected patients with CF.
RESULTS: Inhibition of the Phox with diphenylene iodonium (DPI) delayed O(2) depletion, nearly abolished staining of O(-)(2)-producing PMNs with hydroethidine and inhibited the rapid luminol-enhanced chemiluminescence in sputum. Furthermore, the total O(2) consumption was correlated to the concentration of PMNs in the sputum samples.
CONCLUSION: The results demonstrate that CF sputum contains PMNs with an active consumption of O(2) for O(-)(2) production and suggest that the respiratory burst is ongoing and causes accelerated O(2) depletion due to formation of O(-)(2) in the lungs of chronically infected patients with CF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846469     DOI: 10.1136/thx.2009.114512

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  63 in total

1.  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Authors:  Athanasios Chatzimoschou; Maria Simitsopoulou; Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 2.  Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?

Authors:  Kamal Dua; Shakti D Shukla; Rakesh K Tekade; Philip M Hansbro
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

3.  Pseudomonas aeruginosa biofilm hampers murine central wound healing by suppression of vascular epithelial growth factor.

Authors:  Hannah Trøstrup; Christian J Lerche; Lars J Christophersen; Kim Thomsen; Peter Ø Jensen; Hans Petter Hougen; Niels Høiby; Claus Moser
Journal:  Int Wound J       Date:  2017-11-27       Impact factor: 3.315

4.  Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection.

Authors:  L J Christophersen; H Trøstrup; D S Malling Damlund; T Bjarnsholt; K Thomsen; P Ø Jensen; H P Hougen; N Høiby; C Moser
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Diffusive transport through a model host-biofilm system.

Authors:  A C Aristotelous; I Klapper; Y Grabovsky; B Pabst; B Pitts; P S Stewart
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2015-08-10

6.  Non-invasive imaging of oxygen concentration in a complex in vitro biofilm infection model using 19 F MRI: Persistence of an oxygen sink despite prolonged antibiotic therapy.

Authors:  Jeffrey W Simkins; Philip S Stewart; Sarah L Codd; Joseph D Seymour
Journal:  Magn Reson Med       Date:  2019-08-02       Impact factor: 4.668

7.  Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Tim Holm Jakobsen; Richard Phipps; Anne Kirstine Nielsen; Morten Theil Rybtke; Tim Tolker-Nielsen; Michael Givskov; Niels Høiby; Oana Ciofu
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

Review 8.  Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

9.  Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms.

Authors:  Wen-Chi Chiang; Martin Nilsson; Peter Østrup Jensen; Niels Høiby; Thomas E Nielsen; Michael Givskov; Tim Tolker-Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

10.  Microsensor and transcriptomic signatures of oxygen depletion in biofilms associated with chronic wounds.

Authors:  Garth A James; Alice Ge Zhao; Marcia Usui; Robert A Underwood; Hung Nguyen; Haluk Beyenal; Elinor deLancey Pulcini; Alessandra Agostinho Hunt; Hans C Bernstein; Philip Fleckman; John Olerud; Kerry S Williamson; Michael J Franklin; Philip S Stewart
Journal:  Wound Repair Regen       Date:  2016-02-16       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.